Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Catalent, inc. symbols : Dhr save search
Global Viral & Non-Viral Vector Manufacturing Market 2023 to 2027: Growing Prominence of Gene and Cell Therapy Products Fuels the Sector
Published: 2023-07-03 (Crawled : 22:00) - prnewswire.com
LZAGY | $55.69 0.02% 29K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
CTLT | $56.03 -0.04% 0.0% 1.5M
|
Health Technology
| Email alert
Add to watchlist
TMO | News | $574.59 4.78% -1.12% 2.5M
|
Health Technology
| Email alert
Add to watchlist
DHR | $253.11 7.21% 0.0% 6.8M
|
Health Technology
| Email alert
Add to watchlist
LZAGF | $541.144 -19.1% 24
|
Health Technology
| Email alert
Add to watchlist
cell global growing therapy market
Global Viral and Non-Viral Vector Manufacturing Market Trends to 2031: Rise in Demand for Synthetic Genes and Emergence of Next-Generation Vectors
Published: 2022-02-21 (Crawled : 12:00) - prnewswire.com
LZAGF | $541.144 -19.1% 24
|
Health Technology
| Email alert
Add to watchlist
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
| Email alert
Add to watchlist
TMO | News | $574.59 4.78% -1.12% 2.5M
|
Health Technology
| Email alert
Add to watchlist
CVAC | $2.585 2.17% 2.13% 610K
|
Health Technology
| Email alert
Add to watchlist
CTLT | $56.03 -0.04% 0.0% 1.5M
|
Health Technology
| Email alert
Add to watchlist
LZAGY | $55.69 0.02% 29K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
DHR | $253.11 7.21% 0.0% 6.8M
|
Health Technology
| Email alert
Add to watchlist
ema merge
Worldwide Pharmaceutical Contract Development & Manufacturing Industry to 2026 - Growing Need for Cell and Gene Therapies Presents Opportunities
Published: 2021-12-14 (Crawled : 11:00) - prnewswire.com
LZAGF | $541.144 -19.1% 24
|
Health Technology
|
| O: -2.62%
H: 0.0%
C: 0.0%
LZAGY | $55.69 0.02% 29K
|
Professional, Scientific, and T...
|
| O: -1.64%
H: 0.19%
C: -0.71%
TMO | News | $574.59 4.78% -1.12% 2.5M
|
Health Technology
|
| O: -0.2%
H: 0.0%
C: 0.0%
DHR | $253.11 7.21% 0.0% 6.8M
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: 0.0%
CTLT | $56.03 -0.04% 0.0% 1.5M
|
Health Technology
|
| O: 0.26%
H: 0.44%
C: -0.68%
contract cel gene therapies growing gene therapy therapy
Global In-vitro Toxicology Testing Market 2021-2028 - Ongoing Developments & Rise in Government Funding for Toxicology Research
Published: 2021-10-11 (Crawled : 14:00) - prnewswire.com
DGX | News | $136.7 5.08% 0.0% 2.1M
|
Health Services
|
| O: 0.05%
H: 0.24%
C: -1.15%
LH M | $207.97 2.41% 0.0% 930K
|
Health Services
|
| O: -0.3%
H: 0.19%
C: -1.19%
DHR | $253.11 7.21% 0.0% 6.8M
|
Health Technology
|
| O: -0.16%
H: 1.06%
C: -0.19%
CRL | News | $240.13 3.26% 0.0% 610K
|
Commercial Services
|
| O: -0.71%
H: 1.19%
C: 0.37%
CTLT | $56.03 -0.04% 0.0% 1.5M
|
Health Technology
|
| O: -0.64%
H: 0.52%
C: -0.76%
BIO | $285.28 1.84% 0.0% 230K
|
Health Technology
|
| O: -0.36%
H: 0.88%
C: -0.19%
funding ongoing test research in vitro
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.